Lack of Association Between GSTM1 and GSTT1 Polymorphisms and Brain Tumour Risk |
Sima, Xiu-Tian
(Department of Neurosurgery, West China Hospital of Sichuan University)
Zhong, Wei-Ying (Department of Neurosurgery, West China Hospital of Sichuan University) Liu, Jian-Gang (Department of Neurosurgery, Shenzhen Children Hospital) You, Chao (Department of Neurosurgery, West China Hospital of Sichuan University) |
1 | Lai R, Crevier L, Thabane L (2005). Genetic polymorphisms of glutathione S-transferases and the risk of adult brain tumors: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 14, 1784-90. DOI |
2 | Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48. |
3 | Norppa H (2004). Cytogenetic biomarkers and genetic polymorphisms. Toxicol Lett, 149, 309-34. DOI |
4 | Pinarbasi H, Silig Y, Gurelik M (2005). Genetic polymorphisms of GSTs and their association with primary brain tumor incidence. Cancer Genet Cytogenet, 156, 144-9. DOI |
5 | Schwartzbaum JA, Ahlbom A, Lonn S, et al (2007). An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumors. Cancer Epidemiol Biomarkers Prev, 16, 559-65. DOI |
6 | Trizna Z, De Andrade M, Kyritsis AP, et al (1998). Genetic polymorphisms in glutathione S-transferase (mu) and (theta), N- acetyltransferase, and CYP1A1 and risk of gliomas. Cancer Epidemiology Biomarkers and Prevention, 7, 553-5. |
7 | Wrensch M, Kelsey KT, Liu M, et al (2004). Glutathione-Stransferase variants and adult glioma. Cancer Epidemiol Biomarkers Prev, 13, 461-7. |
8 | De Roos AJ, Rothman N, Inskip PD, et al (2003). Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev, 12, 14-22. |
9 | DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88. DOI |
10 | Elexpuru-Camiruaga J, Buxton N, Kandula V, et al (1995). Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione S-transferase (GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) loci. Cancer Res, 55, 4237-9. |
11 | Ezer R, Alonso M, Pereira E, et al (2002). Identification of glutathione S-transferase (GST) polymorphisms in brain tumors and association with susceptibility to pediatric astrocytomas. J Neurooncol, 59, 123-34. DOI |
12 | Fisher JL, Schwartzbaum JA, Wrensch M, et al (2007). Epidemiology of brain tumors. Neurol Clin, 25, 867-90. DOI |
13 | Hayes JD, Pulford DJ (1995). The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol, 30, 445-600. DOI |
14 | Hayes JD, Strange RC (2000). Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology, 61, 154-66. DOI |
15 | Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58. DOI |
16 | Inskip PD, Linet MS, Heineman EF (1995). Etiology of brain tumors in adults. Epidemiol Rev, 17, 382-414. DOI |
17 | Jemal A, Siegel R, Xu J, et al (2010). Cancer statistics, 2010. CA Cancer J Clin, 60, 277-300. DOI |
18 | Kondratieva TV, Imyanitov EN, Togo AV, et al (2000). L-MYC and GSTM1 polymorphisms are associated with unfavourable clinical parameters of gliomas. J Exp Clin Cancer Res, 19, 197-200. |
19 | Coles BF, Kadlubar FF (2003). Detoxification of electrophilic compounds by glutathione S-transferase catalysis: determinants of individual response to chemical carcinogens and chemotherapeutic drugs? Biofactors, 17, 115-30. DOI |
20 | Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101. DOI |
21 | Custodio AC, Almeida LO, Pinto GR, et al (2010). GSTP1 Ile105Val polymorphism in astrocytomas and glioblastomas. Genet Mol Res, 9, 2328-34. DOI |